查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751202

口服固體製劑CDMO市場規模、佔有率、趨勢分析報告：依產品、機制、治療適應症、最終用途、地區、細分市場預測，2025-2030年

Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules), By Mechanism (Immediate Release, Delayed Release), By Drug Potency, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 262 Pages | 商品交期: 2-10個工作天內

價格

口服固體製劑CDMO 市場的成長與趨勢：

預計到 2030 年，全球口服固體製劑CDMO 市場規模將達到 635 億美元，2025 年至 2030 年的複合年成長率為 6.49%。

製藥公司和生物製藥公司對口服固體製劑外包生產的需求日益成長，這迫使合約開發與受託製造廠商(CDMO) 擴大其生產設施，以滿足製藥公司的需求。此類擴建正在全球範圍內進行，以提高其在口服固體製劑行業的滲透率。此外，作為口服固體製劑 (OSD) 產品的學名藥數量也在增加，因此，對學名藥日益成長的需求是市場成長的主要驅動力。

慢性病和感染疾病患者數量的不斷成長是推動新型治療藥物需求的主要因素，從而對該行業的整體發展產生了積極影響。此外，老年人口的快速成長（老年人易患慢性病）以及老年族群局部外用藥物（OSD）的高採用率，也進一步推動了OSD的需求。此外，現有藥物的不良反應也推動了對新型治療方案的需求，也促進了市場的成長。

口服固體製劑CDMO市場持續推動技術進步，以提高生產效率、產品品質和法規遵從性，進而對整體市場成長潛力產生正面影響。連續生產有助於無縫整合眾多單元操作，從而簡化生產工作流程，並提高口服固體製劑生產的靈活性。此外，層析法、光譜法、質譜法和溶離度測試等技術進步使CDMO能夠提高藥物分析的準確性、靈敏度和可靠性。此外，自動化、機器人技術和數據分析的整合簡化了分析工作流程，縮短了周轉時間，提高了數據完整性，並符合良好生產規範（GMP）和國際協調會議（ICH）指南等監管標準。

口服固體製劑CDMO市場報告重點

  • 從產品角度來看，錠劑領域將在 2024 年佔據市場主導地位。該領域的高成長得益於研發活動投資的增加、製造流程的技術進步、創新的藥物輸送方式，以及對先進解決方案日益成長的需求，以滿足高市場需求。
  • 根據機制，由於患者依從性提高、療效和安全性增強以及給藥頻率降低，控制釋放預計將在 2024 年佔據最大的市場佔有率。
  • 根據藥物適應症，低效藥物在 2024 年佔據了最大的市場佔有率，這是因為低效藥物的開發和製造過程簡單、對學名藥的需求高，從而需要具有成本效益的解決方案、患者群體龐大以及滲透到多個治療領域以實現有效的患者結果。
  • 根據最終用途，中小企業（SME）部門將佔收益的大部分，到2024年將佔比超過72.34%。該部門的成長歸因於越來越多的中小企業將其生產業務外包給CDMO和CMO。中小企業在配方開發、製程最佳化和口服固體製劑生產方面的資源和能力有限。因此，客戶越來越偏好CDMO來開發和生產口服固體製劑。
  • 預計到2024年，亞太地區將佔據口服固體製劑CDMO市場的36.76%。越來越多的製藥生產外包至包括印度和中國在內的亞洲國家。這導致該地區製藥公司進行的臨床研究數量增加。此外，充足的原料供應和先進的製造基礎設施預計將推動該地區市場的成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章口服固體製劑CDMO 市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術格局
    • 製造技術
    • 封裝技術
    • 塗層技術
    • 包裝技術
    • 分析技術
  • 定價模式分析
  • 口服固態製劑契約製造市場分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章口服固體製劑CDMO 市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 口服固體製劑CDMO市場：產品差異分析
  • 全球口服固體製劑CDMO 市場規模及趨勢分析（依產品，2018-2030 年）
  • 藥片
    • 壓縮片
    • 口溶錠（ODT）
    • 咀嚼片
    • 雙層或三層片劑
    • 舌下或頰片
    • 其他
  • 膠囊
    • 硬明膠膠囊
    • 軟膠囊
  • 粉末
  • 顆粒
  • 其他

第5章口服固體製劑CDMO 市場：依機制的估計與趨勢分析

  • 細分儀表板
  • 口服固體製劑CDMO市場：機制變異分析
  • 全球口服固體製劑CDMO 市場規模及趨勢分析（按機制，2018-2030 年）
  • 即時釋放
  • 延遲釋放
  • 控釋

第6章口服固體製劑CDMO 市場：按藥物適應症的估計和趨勢分析

  • 細分儀表板
  • 口服固體製劑CDMO市場：藥物效力差異分析
  • 全球口服固體製劑CDMO 市場規模及趨勢分析（依藥品適應症，2018-2030 年）
  • 高效藥物
  • 中等效力的藥物
  • 低效藥物

第7章口服固體製劑CDMO 市場：依最終用途的估算與趨勢分析

  • 細分儀表板
  • 口服固體製劑CDMO市場：最終用途差異分析
  • 全球口服固體製劑CDMO 市場規模及趨勢分析（依最終用途，2018-2030 年）
  • 主要企業
  • 中小企業
  • 其他

第 8 章口服固體製劑CDMO 市場：區域評估與趨勢分析、按產品、按機制、按藥物適應症、按最終用途

  • 區域儀表板
  • 口服固體製劑CDMO市場：區域差異分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
    • 市場領導者
    • 新興企業
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Lonza
    • Thermo Fisher Scientific Inc.
    • Cambrex Corporation
    • Catalent Inc.
    • Siegrfried Holding AG
    • Recipharm AB
    • CordenPharma International
    • Boehringer Ingelheim
    • Piramal Pharma Solutions
    • Aenova Group
    • Almac Group
    • Jubilant Pharmova Limited
    • Delpharm
    • AbbVie Contract Manufacturing
    • Next Pharma AB
    • Rubicon Research Pvt. Ltd.
    • Quotient Sciences
    • Almac Group
    • SPI Pharma
    • DPT Laboratories Ltd.
    • Alcami Corporation
Product Code: GVR-4-68040-587-6

Oral Solid Dosage CDMO Market Growth & Trends:

The global oral solid dosage CDMO market size is expected to reach USD 63.50 billion by 2030, and grow at a CAGR of 6.49% from 2025 to 2030. The increasing demand for outsourcing oral solid dosage manufacturing among pharmaceutical and biopharmaceutical companies has compelled contract development and manufacturing organizations (CDMO) to expand their manufacturing facilities to support the demand of pharmaceutical companies. These expansions are made across the globe to enhance their oral solid dosage industry penetration. Furthermore, the rising demand for generic drugs is a key factor for the market growth as there are increasing numbers of generics as OSD products.

The growing number of patients suffering from chronic and infectious diseases is key factor driving demand for novel therapeutics, thereby positively influencing overall industry progression. In addition, Booming geriatric population that are highly prone to chronic diseases and high adoption rate of OSD among this population further supporting the demand for OSD. Furthermore, another factor contributing to the market growth is adverse drug reactions to existing drugs, which have increased the demand for novel treatment options.

Ongoing technological advancements in the oral solid dosage CDMO market to enhance manufacturing efficiency, product quality, and regulatory compliance are positively influencing overall market growth potential. Continuous manufacturing assists seamless integration of numerous unit operations leading to streamlined production workflows and increased flexibility in manufacturing oral solid dosage forms. Moreover, innovations in techniques such as chromatography, spectroscopy, mass spectrometry, and dissolution testing enabled CDMOs to meet enhanced precision, sensitivity, & reliability in pharmaceutical analysis. Furthermore, the integration of automation, robotics, & data analytics streamlined analytical workflows, reduced turnaround times, and enhanced data integrity & compliance with regulatory standards such as Good Manufacturing Practices (GMP) & International Council for Harmonization (ICH) guidelines.

Oral Solid Dosage CDMO Market Report Highlights:

  • Basd on product, the tablets segment dominated the market in 2024. The high segment growth is driven by increasing investment in research and development activities, technological advancements in manufacturing processes, innovative drug delivery options and the growing need for advanced solutions to cater to high market demand.
  • Based on the mechanism, controlled release segment held the largest market share in 2024 attributing to an improved patient compliance, enhanced efficacy & safety, and reduced frequency of administration.
  • Based on the drug potency, low potent drugs segment held the largest market share in 2024 owing to ease of development and manufacturing processes, high demand for generic drugs coupled with need for cost effective solutions, high patient population and high penetration among multiple therapeutic areas to cater effective patient outcome.
  • Based on end use, medium & small-size companies segment held the majority revenue share, accounting for over 72.34% in 2024. Growth in the segment can be attributed to the increasing number of small- & medium-sized companies outsourcing their production work to CDMOs and CMOs. Medium and small-sized pharmaceutical companies have limited resources and capabilities in formulation development, process optimization, and manufacturing of oral solid dosage forms. Thus, growing customer preference towards CDMOs for the development and manufacturing of oral solid dosage.
  • Asia Pacific dominated the oral solid dosage CDMO market with a share of 36.76% in 2024. The outsourcing of pharmaceutical manufacturing to Asian countries, including India and China, has increased due to their lower costs and availability of potential study subjects. This has led to an increase in clinical studies conducted by pharmaceutical companies in the region. Moreover, high availability of raw materials and advanced manufacturing infrastructure will propel regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value Chain-Based Sizing & Forecasting (Model 2)
    • 1.7.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.7.4. Bottom-up Approach (Model 4)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objectives
    • 1.11.1. Objective 1
    • 1.11.2. Objective 2
    • 1.11.3. Objective 3
    • 1.11.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Oral Solid Dosage CDMO Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
      • 3.2.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
      • 3.2.1.3. Increasing Demand for Novel Therapies
      • 3.2.1.4. Increasing Demand for One-Stop-Shop CMOs
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Strict Approval Criteria by Regulatory Authorities
      • 3.2.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
      • 3.2.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
  • 3.3. Technology Landscape
    • 3.3.1. Manufacturing Technology
    • 3.3.2. Encapsulation Technology
    • 3.3.3. Coating Technology
    • 3.3.4. Packaging Technology
    • 3.3.5. Analytical Technology
  • 3.4. Pricing Model Analysis
  • 3.5. Oral Solid Dosage Contract Manufacturing Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Oral Solid Dosage CDMO Market: Product Movement Analysis
  • 4.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Tablets
    • 4.4.1. Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Compressed Tablets
      • 4.4.2.1. Compressed Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Orally Disintegrating Tablets (ODT)
      • 4.4.3.1. Orally Disintegrating Tablets (ODT) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Chewable Tablets
      • 4.4.4.1. Chewable Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Bi-layer or Tri-layer Tablets
      • 4.4.5.1. Bi-layer or Tri-layer Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Sublingual or Buccal Tablets
      • 4.4.6.1. Sublingual or Buccal Tablets Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Capsules
    • 4.5.1. Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Hard Gelatin Capsules
      • 4.5.2.1. Hard Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Soft Gelatin Capsules
      • 4.5.3.1. Soft Gelatin Capsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Powder
    • 4.6.1. Powder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Granules
    • 4.7.1. Granules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage CDMO Market: Mechanism Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Oral Solid Dosage CDMO Market: Mechanism Movement Analysis
  • 5.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
  • 5.4. Immediate Release
    • 5.4.1. Immediate Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Delayed Release
    • 5.5.1. Delayed Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Controlled Release
    • 5.6.1. Controlled Release Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage CDMO Market: Drug Potency Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Oral Solid Dosage CDMO Market: Drug Potency Movement Analysis
  • 6.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by Drug Potency, 2018 to 2030 (USD Million)
  • 6.4. High Potent Drugs
    • 6.4.1. High Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Moderate Potent Drugs
    • 6.5.1. Moderate Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Low Potent Drugs
    • 6.6.1. Low Potent Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage CDMO Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Oral Solid Dosage CDMO Market: End Use Movement Analysis
  • 7.3. Global Oral Solid Dosage CDMO Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Large Size Companies
    • 7.4.1. Large Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Medium & Small Size Companies
    • 7.5.1. Medium & Small Size Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Oral Solid Dosage CDMO Market: Regional Estimates & Trend Analysis, by Product, by Mechanism, by Drug Potency, by End Use

  • 8.1. Regional Dashboard
  • 8.2. Oral Solid Dosage CDMO Market: Regional Movement Analysis
  • 8.3. North America
    • 8.3.1. North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Lonza
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Thermo Fisher Scientific Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Cambrex Corporation
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Catalent Inc.
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Siegrfried Holding AG
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Recipharm AB
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. CordenPharma International
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Boehringer Ingelheim
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Piramal Pharma Solutions
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Aenova Group
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Almac Group
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Jubilant Pharmova Limited
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Delpharm
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product/Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. AbbVie Contract Manufacturing
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product/Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Next Pharma AB
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product/Service Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. Rubicon Research Pvt. Ltd.
      • 9.3.16.1. Company Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product/Service Benchmarking
      • 9.3.16.4. Strategic Initiatives
    • 9.3.17. Quotient Sciences
      • 9.3.17.1. Company Overview
      • 9.3.17.2. Financial Performance
      • 9.3.17.3. Product/Service Benchmarking
      • 9.3.17.4. Strategic Initiatives
    • 9.3.18. Almac Group
      • 9.3.18.1. Company Overview
      • 9.3.18.2. Financial Performance
      • 9.3.18.3. Product/Service Benchmarking
      • 9.3.18.4. Strategic Initiatives
    • 9.3.19. SPI Pharma
      • 9.3.19.1. Company Overview
      • 9.3.19.2. Financial Performance
      • 9.3.19.3. Product/Service Benchmarking
      • 9.3.19.4. Strategic Initiatives
    • 9.3.20. DPT Laboratories Ltd.
      • 9.3.20.1. Company Overview
      • 9.3.20.2. Financial Performance
      • 9.3.20.3. Product/Service Benchmarking
      • 9.3.20.4. Strategic Initiatives
    • 9.3.21. Alcami Corporation
      • 9.3.21.1. Company Overview
      • 9.3.21.2. Financial Performance
      • 9.3.21.3. Product/Service Benchmarking
      • 9.3.21.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 5 Global Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 6 Global Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 7 Global Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 8 Global Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Global Oral Solid Dosage CDMO Market, by Region, 2018 - 2030 (USD Million)
  • Table 10 North America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 11 North America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 North America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 13 North America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 14 North America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 15 North America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 16 North America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 U.S Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 19 U.S Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 20 U.S Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 21 U.S Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 22 U.S Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Canada Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Canada Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 25 Canada Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 26 Canada Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 27 Canada Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 28 Canada Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Mexico Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Mexico Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 31 Mexico Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 32 Mexico Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 33 Mexico Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 34 Mexico Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Europe Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 36 Europe Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 Europe Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 38 Europe Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 39 Europe Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 40 Europe Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 41 Europe Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Germany Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Germany Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 44 Germany Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 45 Germany Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 46 Germany Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 47 Germany Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 UK Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 UK Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 50 UK Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 51 UK Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 52 UK Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 53 UK Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 France Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 France Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 56 France Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 57 France Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 58 France Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 59 France Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Italy Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Italy Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 62 Italy Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 63 Italy Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 64 Italy Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 65 Italy Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Spain Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Spain Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 68 Spain Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 69 Spain Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 70 Spain Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 71 Spain Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Denmark Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Denmark Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 74 Denmark Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 75 Denmark Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 76 Denmark Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 77 Denmark Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 78 Sweden Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Sweden Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 80 Sweden Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 81 Sweden Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 82 Sweden Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 83 Sweden Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 84 Norway Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Norway Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 86 Norway Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 87 Norway Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 88 Norway Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 89 Norway Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 90 Asia Pacific Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 91 Asia Pacific Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 Asia Pacific Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 93 Asia Pacific Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 94 Asia Pacific Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 95 Asia Pacific Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 China Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 China Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 99 China Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 100 China Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 101 China Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 102 China Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 103 Japan Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 104 Japan Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 105 Japan Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 106 Japan Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 107 Japan Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 108 Japan Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 India Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 India Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 111 India Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 112 India Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 113 India Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 114 India Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 115 South Korea Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 South Korea Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 117 South Korea Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 118 South Korea Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 119 South Korea Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 120 South Korea Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121 Australia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Australia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 123 Australia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 124 Australia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 125 Australia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 126 Australia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 127 Thailand Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 128 Thailand Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 129 Thailand Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 130 Thailand Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 131 Thailand Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 132 Thailand Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 133 Latin America Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 134 Latin America Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 Latin America Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 136 Latin America Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 137 Latin America Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 138 Latin America Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 139 Latin America Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 140 Brazil Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 141 Brazil Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 142 Brazil Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 143 Brazil Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 144 Brazil Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 145 Brazil Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 146 Argentina Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 Argentina Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 148 Argentina Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 149 Argentina Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 150 Argentina Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 151 Argentina Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 152 Middle East & Africa Oral Solid Dosage CDMO Market, by Country, 2018 - 2030 (USD Million)
  • Table 153 Middle East & Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 154 Middle East & Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 155 Middle East & Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 156 Middle East & Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 157 Middle East & Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 158 Middle East & Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 159 South Africa Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 160 South Africa Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 161 South Africa Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 162 South Africa Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 163 South Africa Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 164 South Africa Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 165 Saudi Arabia Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 166 Saudi Arabia Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 170 Saudi Arabia Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 171 UAE Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 172 UAE Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 173 UAE Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 174 UAE Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 175 UAE Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 176 UAE Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)
  • Table 177 Kuwait Oral Solid Dosage CDMO Market, by Product, 2018 - 2030 (USD Million)
  • Table 178 Kuwait Oral Solid Dosage CDMO Market, by Tablets, 2018 - 2030 (USD Million)
  • Table 179 Kuwait Oral Solid Dosage CDMO Market, by Capsules, 2018 - 2030 (USD Million)
  • Table 180 Kuwait Oral Solid Dosage CDMO Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 181 Kuwait Oral Solid Dosage CDMO Market, by Drug Potency, 2018 - 2030 (USD Million)
  • Table 182 Kuwait Oral Solid Dosage CDMO Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Oral Solid Dosage CDMO, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Oral Solid Dosage CDMO, for Tablets, 2018 - 2030 (USD Million)
  • Fig. 13 Global Oral Solid Dosage CDMO, for Compressed Tablets, 2018 - 2030 (USD Million)
  • Fig. 14 Global Oral Solid Dosage CDMO, for Orally Disintegrating Tablets (ODT), 2018 - 2030 (USD Million)
  • Fig. 15 Global Oral Solid Dosage CDMO, for Chewable Tablets, 2018 - 2030 (USD Million)
  • Fig. 16 Global Oral Solid Dosage CDMO, for Bi-layer or Tri-layer Tablets, 2018 - 2030 (USD Million)
  • Fig. 17 Global Oral Solid Dosage CDMO, for Sublingual or Buccal Tablets, 2018 - 2030 (USD Million)
  • Fig. 18 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Oral Solid Dosage CDMO, for Hard Gelatin Capsules, 2018 - 2030 (USD Million)
  • Fig. 20 Global Oral Solid Dosage CDMO, for Soft Gelatin Capsules, 2018 - 2030 (USD Million)
  • Fig. 21 Global Oral Solid Dosage CDMO, for Immediate Release, 2018 - 2030 (USD Million)
  • Fig. 22 Global Oral Solid Dosage CDMO, for Delayed Release, 2018 - 2030 (USD Million)
  • Fig. 23 Global Oral Solid Dosage CDMO, for Controlled Release, 2018 - 2030 (USD Million)
  • Fig. 24 Global Oral Solid Dosage CDMO, for High Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 25 Global Oral Solid Dosage CDMO, for Moderate Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 26 Global Oral Solid Dosage CDMO, for Low Potent Drugs, 2018 - 2030 (USD Million)
  • Fig. 27 Global Oral Solid Dosage CDMO, for Large Size Companies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Oral Solid Dosage CDMO, for Medium & Small Size Companies, 2018 - 2030 (USD Million)
  • Fig. 29 Global Oral Solid Dosage CDMO, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 North America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Oral Solid Dosage CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)